RE: the one thing that stands out9 Jul 2018 12:10
They are doing a good job, 25 million is peanuts in this game and they have 1 drug coming to an end of stage 2 trials and one drug is entering stage 3 trials thats an enormous acheivment on such little funds. Not to mention 101 and 301 ready for human trialling. The only thing they have done wrong is fundraising from dodgy companies but beggers can't be choosers. The share price in this share is based on sentinment and that is so low, maybe thats got something to do with all the negativity floating around on here.